Report Detail
Global iPSC-Derived Cardiomyocytes Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4724839 |
- 03 August, 2026 |
- Global |
- 88 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global iPSC-Derived Cardiomyocytes market size was valued at US$ 896 million in 2025 and is forecast to a readjusted size of US$ 1754 million by 2032 with a CAGR of 10.2% during review period.
iPSC-Derived Cardiomyocytes are human cardiomyocyte products generated through directed cardiac differentiation, purification, maturation, and quality control of induced pluripotent stem cells (iPSCs). They include ventricular-like, atrial-like, nodal-like, and mixed cardiomyocyte populations, and are typically supplied as cryopreserved cells, plate-ready cultures, or three-dimensional cardiac microtissues. These products are characterized by the expression of cardiac-specific biomarkers, spontaneous beating activity, action potential profiles, calcium transient dynamics, contractile force, batch-to-batch consistency, post-thaw viability, and validated sterility and mycoplasma-free status. They are widely used in cardiac safety assessment, drug screening, disease modeling, electrophysiological research, and early-stage regenerative medicine development. The overall gross margin is approximately 62%.
Demand for iPSC-derived cardiomyocytes is primarily driven by pharmaceutical companies and CROs seeking human-relevant cardiac models for drug safety evaluation. Conventional animal models and immortalized cell lines often fail to accurately reproduce human cardiac ion channel function, contractility, and genetic diversity. In contrast, iPSC-derived cardiomyocytes provide reproducible testing platforms compatible with multielectrode array (MEA), calcium imaging, patch-clamp electrophysiology, impedance measurement, and three-dimensional cardiac tissue models, making them well suited for early-stage drug discovery and preclinical cardiac risk assessment.
Product development is focused on well-defined cardiac subtypes, enhanced cellular maturation, improved batch consistency, and scalable manufacturing. Leading suppliers are expanding beyond standard cryopreserved cardiomyocytes to offer plate-ready cells, disease-specific models, isogenic control cell lines, and three-dimensional cardiac microtissues. These products are increasingly integrated with automated cell culture systems, functional assay platforms, and GMP-compatible manufacturing processes, enhancing their translational value for pharmaceutical research and regenerative medicine development.
Regional opportunities are concentrated in North America, Europe, and Japan, supported by continued investment in cardiovascular drug development, implementation of the CiPA (Comprehensive in vitro Proarrhythmia Assay) initiative for cardiac safety evaluation, and expanding regenerative medicine research. Short-term challenges include incomplete cellular maturation, functional variability between production batches, relatively high product costs, and increasingly stringent quality control requirements. Nevertheless, continued advances in large-scale differentiation, cryopreservation technologies, and functional validation methods are expected to drive sustained growth in commercial adoption.
Report Scope
This report is a detailed and comprehensive analysis for global iPSC-Derived Cardiomyocytes market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global iPSC-Derived Cardiomyocytes market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Cardiomyocytes market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Cardiomyocytes market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Cardiomyocytes market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for iPSC-Derived Cardiomyocytes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global iPSC-Derived Cardiomyocytes market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FUJIFILM Cellular Dynamics, Ncardia, Axol Bioscience, REPROCELL, NEXEL, Curi Bio, Creative Bioarray, Applied StemCell, BPS Bioscience, Cell Applications, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
iPSC-Derived Cardiomyocytes market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ventricular-Like Cardiomyocytes
Atrial-Like Cardiomyocytes
Nodal-Like Cardiomyocytes
Mixed Cardiomyocytes
Cardiac Progenitor-Derived Cardiomyocytes
Market segment by Donor and Genetic Background
Healthy Donor Cells
Patient-Derived Disease Cells
Gene-Edited Disease Cells
Isogenic Control Cells
Custom Line-Derived Cells
Market segment by Delivery Format
Cryopreserved Cell Vials
Plate-Ready Cells
Assay Kits With Media
3D Cardiac Microtissues
Custom Differentiation Lots
Market segment by Validation Grade
Standard Research Grade
Assay-Ready Grade
Electrophysiology Validated Grade
High-Throughput Screening Grade
GMP-Compatible Development Grade
Market segment by Application
Cardiotoxicity Testing
Drug Discovery and Screening
Disease Modeling
Electrophysiology and Contractility Assays
Regenerative Medicine Research
Cardiac Tissue Engineering
Major players covered
FUJIFILM Cellular Dynamics
Ncardia
Axol Bioscience
REPROCELL
NEXEL
Curi Bio
Creative Bioarray
Applied StemCell
BPS Bioscience
Cell Applications
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe iPSC-Derived Cardiomyocytes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of iPSC-Derived Cardiomyocytes, with price, sales quantity, revenue, and global market share of iPSC-Derived Cardiomyocytes from 2021 to 2026.
Chapter 3, the iPSC-Derived Cardiomyocytes competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the iPSC-Derived Cardiomyocytes breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and iPSC-Derived Cardiomyocytes market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of iPSC-Derived Cardiomyocytes.
Chapter 14 and 15, to describe iPSC-Derived Cardiomyocytes sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global iPSC-Derived Cardiomyocytes Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Ventricular-Like Cardiomyocytes
- 1.3.3 Atrial-Like Cardiomyocytes
- 1.3.4 Nodal-Like Cardiomyocytes
- 1.3.5 Mixed Cardiomyocytes
- 1.3.6 Cardiac Progenitor-Derived Cardiomyocytes
- 1.4 Market Analysis by Donor and Genetic Background
- 1.4.1 Overview: Global iPSC-Derived Cardiomyocytes Consumption Value by Donor and Genetic Background: 2021 Versus 2025 Versus 2032
- 1.4.2 Healthy Donor Cells
- 1.4.3 Patient-Derived Disease Cells
- 1.4.4 Gene-Edited Disease Cells
- 1.4.5 Isogenic Control Cells
- 1.4.6 Custom Line-Derived Cells
- 1.5 Market Analysis by Delivery Format
- 1.5.1 Overview: Global iPSC-Derived Cardiomyocytes Consumption Value by Delivery Format: 2021 Versus 2025 Versus 2032
- 1.5.2 Cryopreserved Cell Vials
- 1.5.3 Plate-Ready Cells
- 1.5.4 Assay Kits With Media
- 1.5.5 3D Cardiac Microtissues
- 1.5.6 Custom Differentiation Lots
- 1.6 Market Analysis by Validation Grade
- 1.6.1 Overview: Global iPSC-Derived Cardiomyocytes Consumption Value by Validation Grade: 2021 Versus 2025 Versus 2032
- 1.6.2 Standard Research Grade
- 1.6.3 Assay-Ready Grade
- 1.6.4 Electrophysiology Validated Grade
- 1.6.5 High-Throughput Screening Grade
- 1.6.6 GMP-Compatible Development Grade
- 1.7 Market Analysis by Application
- 1.7.1 Overview: Global iPSC-Derived Cardiomyocytes Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Cardiotoxicity Testing
- 1.7.3 Drug Discovery and Screening
- 1.7.4 Disease Modeling
- 1.7.5 Electrophysiology and Contractility Assays
- 1.7.6 Regenerative Medicine Research
- 1.7.7 Cardiac Tissue Engineering
- 1.8 Global iPSC-Derived Cardiomyocytes Market Size & Forecast
- 1.8.1 Global iPSC-Derived Cardiomyocytes Consumption Value (2021 & 2025 & 2032)
- 1.8.2 Global iPSC-Derived Cardiomyocytes Sales Quantity (2021-2032)
- 1.8.3 Global iPSC-Derived Cardiomyocytes Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 FUJIFILM Cellular Dynamics
- 2.1.1 FUJIFILM Cellular Dynamics Details
- 2.1.2 FUJIFILM Cellular Dynamics Major Business
- 2.1.3 FUJIFILM Cellular Dynamics iPSC-Derived Cardiomyocytes Product and Services
- 2.1.4 FUJIFILM Cellular Dynamics iPSC-Derived Cardiomyocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 FUJIFILM Cellular Dynamics Recent Developments/Updates
- 2.2 Ncardia
- 2.2.1 Ncardia Details
- 2.2.2 Ncardia Major Business
- 2.2.3 Ncardia iPSC-Derived Cardiomyocytes Product and Services
- 2.2.4 Ncardia iPSC-Derived Cardiomyocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Ncardia Recent Developments/Updates
- 2.3 Axol Bioscience
- 2.3.1 Axol Bioscience Details
- 2.3.2 Axol Bioscience Major Business
- 2.3.3 Axol Bioscience iPSC-Derived Cardiomyocytes Product and Services
- 2.3.4 Axol Bioscience iPSC-Derived Cardiomyocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Axol Bioscience Recent Developments/Updates
- 2.4 REPROCELL
- 2.4.1 REPROCELL Details
- 2.4.2 REPROCELL Major Business
- 2.4.3 REPROCELL iPSC-Derived Cardiomyocytes Product and Services
- 2.4.4 REPROCELL iPSC-Derived Cardiomyocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 REPROCELL Recent Developments/Updates
- 2.5 NEXEL
- 2.5.1 NEXEL Details
- 2.5.2 NEXEL Major Business
- 2.5.3 NEXEL iPSC-Derived Cardiomyocytes Product and Services
- 2.5.4 NEXEL iPSC-Derived Cardiomyocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 NEXEL Recent Developments/Updates
- 2.6 Curi Bio
- 2.6.1 Curi Bio Details
- 2.6.2 Curi Bio Major Business
- 2.6.3 Curi Bio iPSC-Derived Cardiomyocytes Product and Services
- 2.6.4 Curi Bio iPSC-Derived Cardiomyocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Curi Bio Recent Developments/Updates
- 2.7 Creative Bioarray
- 2.7.1 Creative Bioarray Details
- 2.7.2 Creative Bioarray Major Business
- 2.7.3 Creative Bioarray iPSC-Derived Cardiomyocytes Product and Services
- 2.7.4 Creative Bioarray iPSC-Derived Cardiomyocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Creative Bioarray Recent Developments/Updates
- 2.8 Applied StemCell
- 2.8.1 Applied StemCell Details
- 2.8.2 Applied StemCell Major Business
- 2.8.3 Applied StemCell iPSC-Derived Cardiomyocytes Product and Services
- 2.8.4 Applied StemCell iPSC-Derived Cardiomyocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Applied StemCell Recent Developments/Updates
- 2.9 BPS Bioscience
- 2.9.1 BPS Bioscience Details
- 2.9.2 BPS Bioscience Major Business
- 2.9.3 BPS Bioscience iPSC-Derived Cardiomyocytes Product and Services
- 2.9.4 BPS Bioscience iPSC-Derived Cardiomyocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 BPS Bioscience Recent Developments/Updates
- 2.10 Cell Applications
- 2.10.1 Cell Applications Details
- 2.10.2 Cell Applications Major Business
- 2.10.3 Cell Applications iPSC-Derived Cardiomyocytes Product and Services
- 2.10.4 Cell Applications iPSC-Derived Cardiomyocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Cell Applications Recent Developments/Updates
3 Competitive Environment: iPSC-Derived Cardiomyocytes by Manufacturer
- 3.1 Global iPSC-Derived Cardiomyocytes Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global iPSC-Derived Cardiomyocytes Revenue by Manufacturer (2021-2026)
- 3.3 Global iPSC-Derived Cardiomyocytes Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of iPSC-Derived Cardiomyocytes by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 iPSC-Derived Cardiomyocytes Manufacturer Market Share in 2025
- 3.4.3 Top 6 iPSC-Derived Cardiomyocytes Manufacturer Market Share in 2025
- 3.5 iPSC-Derived Cardiomyocytes Market: Overall Company Footprint Analysis
- 3.5.1 iPSC-Derived Cardiomyocytes Market: Region Footprint
- 3.5.2 iPSC-Derived Cardiomyocytes Market: Company Product Type Footprint
- 3.5.3 iPSC-Derived Cardiomyocytes Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global iPSC-Derived Cardiomyocytes Market Size by Region
- 4.1.1 Global iPSC-Derived Cardiomyocytes Sales Quantity by Region (2021-2032)
- 4.1.2 Global iPSC-Derived Cardiomyocytes Consumption Value by Region (2021-2032)
- 4.1.3 Global iPSC-Derived Cardiomyocytes Average Price by Region (2021-2032)
- 4.2 North America iPSC-Derived Cardiomyocytes Consumption Value (2021-2032)
- 4.3 Europe iPSC-Derived Cardiomyocytes Consumption Value (2021-2032)
- 4.4 Asia-Pacific iPSC-Derived Cardiomyocytes Consumption Value (2021-2032)
- 4.5 South America iPSC-Derived Cardiomyocytes Consumption Value (2021-2032)
- 4.6 Middle East & Africa iPSC-Derived Cardiomyocytes Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global iPSC-Derived Cardiomyocytes Sales Quantity by Type (2021-2032)
- 5.2 Global iPSC-Derived Cardiomyocytes Consumption Value by Type (2021-2032)
- 5.3 Global iPSC-Derived Cardiomyocytes Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global iPSC-Derived Cardiomyocytes Sales Quantity by Application (2021-2032)
- 6.2 Global iPSC-Derived Cardiomyocytes Consumption Value by Application (2021-2032)
- 6.3 Global iPSC-Derived Cardiomyocytes Average Price by Application (2021-2032)
7 North America
- 7.1 North America iPSC-Derived Cardiomyocytes Sales Quantity by Type (2021-2032)
- 7.2 North America iPSC-Derived Cardiomyocytes Sales Quantity by Application (2021-2032)
- 7.3 North America iPSC-Derived Cardiomyocytes Market Size by Country
- 7.3.1 North America iPSC-Derived Cardiomyocytes Sales Quantity by Country (2021-2032)
- 7.3.2 North America iPSC-Derived Cardiomyocytes Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe iPSC-Derived Cardiomyocytes Sales Quantity by Type (2021-2032)
- 8.2 Europe iPSC-Derived Cardiomyocytes Sales Quantity by Application (2021-2032)
- 8.3 Europe iPSC-Derived Cardiomyocytes Market Size by Country
- 8.3.1 Europe iPSC-Derived Cardiomyocytes Sales Quantity by Country (2021-2032)
- 8.3.2 Europe iPSC-Derived Cardiomyocytes Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific iPSC-Derived Cardiomyocytes Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific iPSC-Derived Cardiomyocytes Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific iPSC-Derived Cardiomyocytes Market Size by Region
- 9.3.1 Asia-Pacific iPSC-Derived Cardiomyocytes Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific iPSC-Derived Cardiomyocytes Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America iPSC-Derived Cardiomyocytes Sales Quantity by Type (2021-2032)
- 10.2 South America iPSC-Derived Cardiomyocytes Sales Quantity by Application (2021-2032)
- 10.3 South America iPSC-Derived Cardiomyocytes Market Size by Country
- 10.3.1 South America iPSC-Derived Cardiomyocytes Sales Quantity by Country (2021-2032)
- 10.3.2 South America iPSC-Derived Cardiomyocytes Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa iPSC-Derived Cardiomyocytes Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa iPSC-Derived Cardiomyocytes Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa iPSC-Derived Cardiomyocytes Market Size by Country
- 11.3.1 Middle East & Africa iPSC-Derived Cardiomyocytes Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa iPSC-Derived Cardiomyocytes Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 iPSC-Derived Cardiomyocytes Market Drivers
- 12.2 iPSC-Derived Cardiomyocytes Market Restraints
- 12.3 iPSC-Derived Cardiomyocytes Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of iPSC-Derived Cardiomyocytes and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of iPSC-Derived Cardiomyocytes
- 13.3 iPSC-Derived Cardiomyocytes Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 iPSC-Derived Cardiomyocytes Typical Distributors
- 14.3 iPSC-Derived Cardiomyocytes Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on iPSC-Derived Cardiomyocytes. Industry analysis & Market Report on iPSC-Derived Cardiomyocytes is a syndicated market report, published as Global iPSC-Derived Cardiomyocytes Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of iPSC-Derived Cardiomyocytes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
